Adjuvant Concurrent Chemoradiation and Chemotherapy for High Risk Non-Metastatic Endometrial Cancer

被引：0
|
作者：
Rajan, R. [1 ]
Kunheri, D. B. [2 ]
Tatineni, D. T. [2 ]
机构：
[1] Amrita Inst Med Sci, Dept Radiat Oncol, Kochi, India
[2] Amrita Inst Med Sci, Dept Radiat Oncol, Kochin, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1131
引用
收藏
页码：S597 / S597
页数：1
相关论文
共 50 条
  • [1] Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer
    Ren, Yulan
    Huang, Xiaowei
    Shan, Boer
    Wu, Xiaohua
    Huang, Xiao
    Shi, Daren
    Wang, Huaying
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 58 - 63
  • [2] Concurrent chemoradiation of patients with inoperable non-metastatic pancreatic cancer
    Awad, I.
    Elawadi, M.
    Elzahi, M.
    Wehba, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S591 - S592
  • [3] Adjuvant chemotherapy and chemoradiation following surgery for high-risk endometrial cancer
    Narayan, K.
    Rischin, D.
    Quinn, M.
    Goh, J. C.
    Cheuk, R.
    Obermair, A.
    Bernshaw, D.
    McClure, B.
    Milner, A.
    Mileshkin, L. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A NEW APPROACH IN ADJUVANT TREATMENT OF HIGH RISK ENDOMETRIAL CANCER: CONCURRENT CHEMORADIATION THERAPY FOLLOWED BY CHEMOTHERAPY IN A CENTRE OF REFERENCE FOR GYNECOLOGIC CANCER
    Ventura Zaa, L.
    Gil-Martin, M.
    Pardo Burdalo, B.
    Chiruzzi, C. H.
    Verdaguer Mata, H.
    Navarro Perez, V.
    Bellobi Fava, C.
    De Blas Pinol, R.
    Marin i Borras, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1173 - 1174
  • [5] Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer
    Des Guetz, G.
    Uzzan, B.
    Morere, J. F.
    Perret, G.
    Nicolas, P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [6] Adjuvant chemotherapy for high-risk endometrial cancer
    Pustilnik, T
    Burke, TW
    SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (01) : 23 - 28
  • [7] THE ROLE OF ADJUVANT CHEMOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER
    Colombo, Nicoletta
    Parma, Gabriella
    Lapresa, Maria Teresa
    Mancari, Rosanna
    Peiretti, Michele
    Sanguineti, Fabio
    Festi, Anna
    ANNALS OF ONCOLOGY, 2009, 20 : 9 - 9
  • [8] The docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer
    Hurwitz, Mark D.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S303 - S306
  • [9] Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review
    Robin R. Rodriguez
    Stephen Abel
    Jyothika Mamadgi
    Paul B. Renz
    Rodney E. Wegner
    Moses S. Raj
    Journal of Gastrointestinal Cancer, 2022, 53 : 700 - 708
  • [10] Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review
    Rodriguez, Robin R.
    Abel, Stephen
    Mamadgi, Jyothika
    Renz, Paul B.
    Wegner, Rodney E.
    Raj, Moses S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2022, 53 (03) : 700 - 708
12345